ZEN Stock Overview
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Zentek Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$1.45 |
52 Week High | CA$2.30 |
52 Week Low | CA$1.30 |
Beta | 0.84 |
1 Month Change | -12.12% |
3 Month Change | -13.69% |
1 Year Change | -28.22% |
3 Year Change | -35.84% |
5 Year Change | 297.26% |
Change since IPO | 137.70% |
Recent News & Updates
Recent updates
Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?
Jul 09Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?
Aug 31We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate
Mar 11We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully
Nov 26Shareholder Returns
ZEN | CA Medical Equipment | CA Market | |
---|---|---|---|
7D | -3.3% | 2.3% | 0.7% |
1Y | -28.2% | -26.5% | 4.9% |
Return vs Industry: ZEN underperformed the Canadian Medical Equipment industry which returned -25.7% over the past year.
Return vs Market: ZEN underperformed the Canadian Market which returned 5.5% over the past year.
Price Volatility
ZEN volatility | |
---|---|
ZEN Average Weekly Movement | 7.6% |
Medical Equipment Industry Average Movement | 11.4% |
Market Average Movement | 9.0% |
10% most volatile stocks in CA Market | 18.1% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: ZEN's share price has been volatile over the past 3 months.
Volatility Over Time: ZEN's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | 29 | Greg Fenton | www.zentek.com |
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound.
Zentek Ltd. Fundamentals Summary
ZEN fundamental statistics | |
---|---|
Market cap | CA$146.19m |
Earnings (TTM) | -CA$11.98m |
Revenue (TTM) | CA$33.61k |
4,350x
P/S Ratio-12.2x
P/E RatioIs ZEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ZEN income statement (TTM) | |
---|---|
Revenue | CA$33.61k |
Cost of Revenue | CA$316.44k |
Gross Profit | -CA$282.83k |
Other Expenses | CA$11.69m |
Earnings | -CA$11.98m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.12 |
Gross Margin | -841.52% |
Net Profit Margin | -35,637.65% |
Debt/Equity Ratio | 3.4% |
How did ZEN perform over the long term?
See historical performance and comparison